Omeros (Germany) Top Insiders
| 3O8 Stock | EUR 7.66 0.48 6.69% |
Omeros employs about 213 people. The company is managed by 9 executives with a total tenure of roughly 497 years, averaging almost 55.0 years of service per executive, having 23.67 employees per reported executive. Examination of Omeros' management performance can provide insight into the company performance.
| Nadia Dac Insider VP Officer |
| Debra MT Insider Chief Officer |
Omeros |
Omeros Management Team Effectiveness
The company has return on total asset (ROA) of (0.3574) % which means that it has lost $0.3574 on every $100 spent on assets. This is way below average. Omeros' management efficiency ratios could be used to measure how well Omeros manages its routine affairs as well as how well it operates its assets and liabilities.Omeros Workforce Comparison
Omeros is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 9,558. Omeros holds roughly 213 in number of employees claiming about 2.23% of stocks in Biotechnology industry.
Omeros Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Omeros Price Series Summation is a cross summation of Omeros price series and its benchmark/peer.
Omeros Notable Stakeholders
An Omeros stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Omeros often face trade-offs trying to please all of them. Omeros' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Omeros' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Nadia Dac | VP Officer | Profile | |
| Debra MT | Chief Officer | Profile | |
| Gregory MD | Chairman, CoFounder | Profile | |
| Peter JD | Gen VP | Profile | |
| Catherine Melfi | Chief Systems | Profile | |
| Michael Jacobsen | VP Officer | Profile | |
| Pamela MD | CoFounder | Profile | |
| Peter Williams | VP HR | Profile | |
| MD JD | VP Officer | Profile |
About Omeros Management Performance
The success or failure of an entity such as Omeros often depends on how effective the management is. Omeros management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Omeros management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Omeros management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, disorders of the central nervous system , and immune-related diseases. The company was incorporated in 1994 and is based in Seattle, Washington. OMEROS CORP operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 236 people.
Omeros Workforce Analysis
Traditionally, organizations such as Omeros use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Omeros within its industry.Omeros Manpower Efficiency
Return on Omeros Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Income Per Employee | 911.9K | |
| Net Income Per Executive | 21.6M |
Complementary Tools for Omeros Stock analysis
When running Omeros' price analysis, check to measure Omeros' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omeros is operating at the current time. Most of Omeros' value examination focuses on studying past and present price action to predict the probability of Omeros' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Omeros' price. Additionally, you may evaluate how the addition of Omeros to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |